• Return to Headlines

Haemonetics Corp Shares Up 50.9% Since SmarTrend's Buy Recommendation (HAE)

By Nick Russo

SmarTrend identified an Uptrend for Haemonetics Corp (NYSE:HAE) on May 1st, 2019 at $89.64. In approximately 4 months, Haemonetics Corp has returned 50.88% as of today's recent price of $135.24.

Haemonetics Corp share prices have moved between a 52-week high of $137.49 and a 52-week low of $80.23 and are now trading 69% above that low price at $135.24 per share. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.9% while the 200-day MA has risen 0.4%.

Haemonetics Corporation, a healthcare company, provides hematology products and solutions. The company operates through five segments: North America Plasma; Americas Blood Center and Hospital; Europe, Middle East and Africa; Asia Pacific; and Japan.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Haemonetics Corp shares.

Log in and add Haemonetics Corp (HAE) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights haemonetics corp

Ticker(s): HAE